Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mona Abaza

Concepts (147)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Otolaryngology
10
2021
70
3.130
Why?
Voice Disorders
8
2017
20
1.660
Why?
Internship and Residency
8
2019
920
1.420
Why?
Personnel Selection
4
2019
62
1.390
Why?
Laryngoscopy
3
2023
90
0.820
Why?
Larynx
3
2015
47
0.730
Why?
Physicians, Women
1
2021
55
0.710
Why?
Learning
1
2023
344
0.660
Why?
Leadership
2
2021
291
0.630
Why?
Treatment Adherence and Compliance
1
2017
18
0.570
Why?
Career Choice
1
2018
177
0.530
Why?
Resilience, Psychological
1
2018
96
0.530
Why?
Deglutition Disorders
1
2017
117
0.510
Why?
Education, Medical
1
2018
214
0.480
Why?
Injections
1
2015
159
0.470
Why?
Simulation Training
1
2015
62
0.460
Why?
Education, Medical, Undergraduate
1
2016
158
0.440
Why?
Voice
2
2017
8
0.430
Why?
Patient Care Team
1
2017
518
0.410
Why?
Burnout, Professional
1
2018
322
0.410
Why?
Occupational Diseases
2
2006
128
0.400
Why?
Vocal Cords
4
2006
25
0.390
Why?
Carcinoma, Hepatocellular
2
2020
210
0.390
Why?
Hepatitis C
2
2020
218
0.360
Why?
Education, Medical, Graduate
3
2019
366
0.330
Why?
Liver Neoplasms
2
2020
504
0.330
Why?
Inhibin-beta Subunits
1
2006
5
0.260
Why?
Activins
1
2006
26
0.260
Why?
Schistosomiasis
1
2006
37
0.250
Why?
Job Application
2
2015
10
0.230
Why?
Insulin-Like Growth Factor I
1
2006
280
0.220
Why?
Humans
25
2023
113531
0.200
Why?
Postpoliomyelitis Syndrome
1
2001
4
0.190
Why?
Glypicans
1
2020
9
0.180
Why?
Dipeptidyl Peptidase 4
1
2020
11
0.180
Why?
Neurofibromatosis 2
2
1998
4
0.170
Why?
Equipment Design
2
2015
496
0.170
Why?
Pilot Projects
2
2019
1356
0.160
Why?
Voice Quality
2
2014
15
0.160
Why?
Disability Evaluation
1
2000
271
0.160
Why?
United States
4
2019
12137
0.150
Why?
Otolaryngologists
1
2017
10
0.140
Why?
Speech-Language Pathology
1
2017
16
0.140
Why?
Educational Status
1
2019
404
0.140
Why?
Organizational Culture
1
2018
120
0.140
Why?
Interviews as Topic
1
2019
574
0.130
Why?
Female
12
2021
59115
0.120
Why?
Faculty, Medical
1
2018
226
0.120
Why?
Clinical Clerkship
1
2016
72
0.120
Why?
Competitive Behavior
1
2015
36
0.120
Why?
Psychoses, Substance-Induced
2
2007
12
0.120
Why?
Dysphonia
1
2014
10
0.120
Why?
Speech Acoustics
1
2014
10
0.120
Why?
Clinical Competence
2
2019
882
0.120
Why?
Cell Division
1
1996
745
0.120
Why?
Program Evaluation
1
2018
821
0.110
Why?
Educational Measurement
1
2016
225
0.110
Why?
Egypt
2
2020
10
0.110
Why?
School Admission Criteria
1
2013
20
0.110
Why?
Attitude
1
2015
227
0.110
Why?
Electromyography
2
2007
323
0.100
Why?
Correspondence as Topic
1
2012
14
0.100
Why?
Male
12
2018
55112
0.100
Why?
Societies, Medical
1
2016
654
0.100
Why?
Students, Medical
1
2016
260
0.100
Why?
Writing
1
2012
81
0.090
Why?
Surgeons
1
2015
235
0.090
Why?
Nasal Decongestants
2
2007
8
0.080
Why?
Histamine H1 Antagonists
2
2007
28
0.080
Why?
Anti-Ulcer Agents
2
2007
15
0.080
Why?
Biomedical Research
1
2015
581
0.080
Why?
Vocal Cord Paralysis
2
2005
21
0.070
Why?
Music
1
2006
35
0.060
Why?
Analgesics
1
2007
156
0.060
Why?
Movement Disorders
1
2005
48
0.060
Why?
Severity of Illness Index
3
2014
2530
0.050
Why?
Glucocorticoids
1
2007
520
0.050
Why?
Vagus Nerve Diseases
1
2002
1
0.050
Why?
Cough
1
2002
108
0.050
Why?
Laryngeal Diseases
1
2001
21
0.050
Why?
Parkinson Disease
1
2005
345
0.050
Why?
Amyloidosis
1
2001
36
0.050
Why?
Middle Aged
6
2006
26552
0.050
Why?
Cicatrix
1
2001
50
0.050
Why?
alpha-Fetoproteins
1
2020
31
0.040
Why?
Gastroesophageal Reflux
1
2002
228
0.040
Why?
Adult
5
2006
30245
0.040
Why?
Audiometry, Pure-Tone
2
1998
20
0.040
Why?
Drug Prescriptions
1
2001
237
0.040
Why?
Hepacivirus
1
2020
228
0.040
Why?
Acute Disease
1
2001
885
0.040
Why?
Ear Neoplasms
1
1998
4
0.040
Why?
Drug-Related Side Effects and Adverse Reactions
1
2001
239
0.040
Why?
Neurilemmoma
1
1998
19
0.040
Why?
Adipose Tissue
1
2001
537
0.040
Why?
Stroke
1
2005
1016
0.030
Why?
Reproducibility of Results
2
2014
2752
0.030
Why?
Spinal Neoplasms
1
1996
26
0.030
Why?
Follow-Up Studies
3
2001
4384
0.030
Why?
Hearing Loss
1
1998
183
0.030
Why?
Speech Production Measurement
1
2014
12
0.030
Why?
Biomarkers, Tumor
1
2020
1029
0.030
Why?
Judgment
1
2014
55
0.030
Why?
Area Under Curve
1
2014
271
0.030
Why?
Signal Processing, Computer-Assisted
1
2014
130
0.030
Why?
Observer Variation
1
2014
298
0.030
Why?
Speech Perception
1
2014
73
0.030
Why?
ROC Curve
1
2014
442
0.030
Why?
Prospective Studies
2
2014
6189
0.030
Why?
Biomarkers
1
2020
3389
0.020
Why?
Predictive Value of Tests
1
2014
1783
0.020
Why?
Aged
3
2005
18944
0.020
Why?
Age Factors
1
1996
2875
0.020
Why?
Patient Selection
1
2012
625
0.020
Why?
Magnetic Resonance Imaging
2
1998
3013
0.020
Why?
Case-Control Studies
1
2014
2993
0.020
Why?
Algorithms
1
2014
1462
0.020
Why?
Risk Assessment
2
2005
2953
0.020
Why?
Brain
1
1996
2309
0.010
Why?
Cross-Sectional Studies
1
2015
4400
0.010
Why?
Age Distribution
1
2005
341
0.010
Why?
Sex Distribution
1
2005
336
0.010
Why?
Surveys and Questionnaires
1
2015
4593
0.010
Why?
Hoarseness
1
2001
4
0.010
Why?
Otorhinolaryngologic Surgical Procedures
1
2001
32
0.010
Why?
Injections, Intramuscular
1
2001
117
0.010
Why?
Biopsy, Needle
1
2001
180
0.010
Why?
Medical History Taking
1
2001
115
0.010
Why?
Transplantation, Autologous
1
2001
174
0.010
Why?
Drug Therapy
1
2001
74
0.010
Why?
Steroids
1
2001
138
0.010
Why?
Drug Utilization
1
2001
164
0.010
Why?
Incidence
1
2005
2310
0.010
Why?
Diagnosis, Differential
1
2002
1328
0.010
Why?
Speech Reception Threshold Test
1
1998
1
0.010
Why?
Reflex, Vestibulo-Ocular
1
1998
9
0.010
Why?
Adolescent
1
1996
17724
0.010
Why?
Prognosis
1
2005
3318
0.010
Why?
Anti-Inflammatory Agents
1
2001
442
0.010
Why?
Evoked Potentials, Auditory, Brain Stem
1
1998
47
0.010
Why?
Child
1
1996
18340
0.010
Why?
Chronic Disease
1
2002
1570
0.010
Why?
Aged, 80 and over
1
2005
6296
0.010
Why?
Retrospective Studies
2
2001
12504
0.010
Why?
Practice Patterns, Physicians'
1
2001
1176
0.010
Why?
Risk Factors
1
2001
8606
0.000
Why?
Treatment Outcome
1
2001
9006
0.000
Why?
Abaza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)